:
Cancer is amongst the leading public health problems globally with continuously increasing prevalence rate that
demands for extensive and expensive treatment. Despite availability of number of potential cancer therapies, inadequate
success has been achieved due to complexity and heterogeneity of tumors. Moreover, late/ terminal stage cancer leads to
multidrug resistance, excruciating side effects, recurrence, etc. This is because of low penetrability and deleterious effects of
drug on non-target cells/ tissues. This requires for cost effective, efficacious, alternative/ adjunct, complementary medicines
with targeted drug delivery approach. A potential strategy to resolve this difficulty is to use theranostics i.e., formulations
having both a therapeutic element and an imaging agent. Phytotherapeutics have been extensively used since times
immemorial, having wide acceptability, easy availability, minimal side effects and comparatively inexpensive. These herbal
formulations are mostly orally administered and thus subjected to adverse pH, enzymatic degradation, poor gut absorption,
low bioavailability and non-targeted delivery that ultimately lead to their poor effectiveness. Constraints associated with
conventional phyto-pharmaceuticals can be improved by designing and using “Nano Delivery Systems” (NDS). The
foremost aim of metal based NDS is to provide sustained drug release, site-specific action, improved patient’s compliance
and enhanced efficacy. Metal Nanocarriers carrying herbal drugs will avoid these obstructions, so the drug can circulate into
the blood for a longer period of time and provide optimal amount of the drug to the site of action. Besides, Herbal drugs
with NDS thus would be efficacious as alternative/ complementary cancer theranostics. Present review describes about
novel theranostic systems employing metal nanocarriers with diagnostic and therapeutic properties as are an effective
strategy for cancer treatment. These systems when conjugated with herbal drugs provide an efficient management strategy
for cancer.